Clinical Trial Update: Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing switching from lamivudine to telbivudine versus continuing lamivudine in adults with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED